Fig. 3From: Strategies for immune regulation in iPS cell-based cardiac regenerative medicineA scheme of the interventional control for immunosuppressive therapy after iPSC-derived heart tissue transplantation. To establish a system to detect immune rejection in daily clinical practices, identification of biomarkers reflecting immune rejection would be anticipated by histological and biochemical evaluations for samples with various immune rejection levelBack to article page